In the journal Cellular Reprogramming Editor-in-Chief Carlos-Filipe Pereira interviews bit.bio CEO Mark Kotter for the Reprogramming Stars profile.
They discuss the latest research and developments in human cellular reprogramming, the discovery of bit.bio's opti-ox™ technology and how this approach could provide a more efficient and effective approach to regenerative medicine, with implications for addressing various health challenges.
Access the article here.
